Glycopezil represents a novel strategy in tackling antibiotic resistance and expanding the selection of drugs available to doctors . This innovative class of agents demonstrates powerful activity against gram+ bacteria, including strains resistant to vancomycin antibiotics. Early studies suggest glycopezil functions via a different pathway of actio

Glycopezil is an innovative antibiotic/antimicrobial/bactericide currently under investigation for its potential to combat resistant/multidrug-resistant/difficult-to-treat bacterial infections. This novel agent exerts its mechanism/activity/effect through a unique process/pathway/mode that targets essential bacterial/cellular/structural processes.